Inovio Pharmaceuticals Inc. Stock Advances 6.7%, Outperforms Market

This article was automatically generated by Dow Jones using technology from Automated Insights.

Shares of Inovio Pharmaceuticals Inc. rose 6.7% to $1.03 on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones Industrial Average rising 1.0% to 52,747.32 and the NASDAQ Composite Index falling 0.2% to 24,876.91.

The stock's rise snapped a four-day losing streak.

Inovio Pharmaceuticals Inc. closed 65.4% below its 52-week high of $2.98, which the company achieved on September 9th.

The stock demonstrated a mixed performance when compared to some of its peers, as Johnson & Johnson rose 0.3% to $266.73, Statera Biopharma Inc. rose 100.0% to $0.00, and Pfizer Inc. rose 2.35% to $25.25.

Trading volume totaled 1.0 million, compared to the 50-day average of 1.8 million.

Data source: Dow Jones Market Data, FactSet

(END) Dow Jones Newswires

July 28, 2026 16:35 ET (20:35 GMT)